The anastomosis devices market was anticipated to register a CAGR of 7.0% during the forecast period. The major factors driving the growth of the market are the increase in the number of cardiac and gastrointestinal surgeries globally. This resulted in increased use during the procedures. Higher demand for surgeries, like CABG (Coronary Artery Bypass Grafting), Partial colectomy, and other thoracic surgeries, due to the global prevalence of various coronary heart diseases and the rise in the geriatric population. For instance, according to WHO, 17.9 million of the population die every year. Additionally, cardiac diseases, like coronary heart disease, hypertension, and stroke, were ranked as the prominent causes of deaths worldwide. Furthermore, the increased adoption of endoscopic surgeries, favorable reimbursement policies, and technological advancements are expected to fuel the growth of the market.
Key Market Trends
The Cardiovascular Surgery Segment is Expected to Hold the Largest Market Share in the Anastomosis Devices Market
Cardiovascular surgeries, by application, are expected to witness the largest market share in the anastomosis devices market during the forecast period. This dominance is due to the increased use of various devices, such as the surgical staplers, and surgical sealants and adhesives in various cardiac surgeries. The increased demand for these devices in aortic surgery, arrhythmia surgery, myectomy, and CABG procedures can be attributed to their ability to minimize the risk of complications and reduce anastomotic leaks. Furthermore, the increasing number of cardiac diseases demands technologically advanced products, propelling the growth of the segment. On the other hand, the gastrointestinal surgeries segment is anticipated to witness the highest CAGR over the course of the forecast period. The lucrative growth of the segment can be due to the rising number of gastrointestinal cancers across the world. As per the American Cancer Society’s estimates for the year 2020, stomach cancer affects about 27,600 and causing 11,010 deaths in the United States. Also, the report states that surgery like endoscopic resection, partial gastrectomy, etc., can only offer a realistic chance for cure of this type of cancer. Thus, the adoption of surgery as an essential part of the treatment for many different stages of stomach cancer is expected to boost the growth of the segment.
North America Dominates the Market and Expected to do Same in the Forecast Period.
North America is expected to dominate the overall anastomosis devices market throughout the forecast period. The major factors attributing to the growth are the increase in the global prevalence of multiple cardiovascular indications, like CAD, strokes, and gastric cancers, like adenocarcinoma, lymphoma, etc., Thus, a rise in surgical procedures increased the demand for these surgical devices. As per the American Heart Association, in 2018, nearly 92.1 million individuals in the US suffered from cardiovascular diseases leading to 3244 heart transplantations. Thus, the higher demand for these devices during surgical procedures drives the market in the region. Deskbound lifestyle, increasing geriatric population with chronic diseases in the region contribute to its outstanding share of revenue propelling the global anastomosis devices market.
The anastomosis market is moderately competitive and consists of several major players. Few of the key players are developing novel products and technologies to compete with the products trending in the market. For instance, in September 2019, Ethicon launched its ECHELON CIRCULAR Powered Circular Stapler which utilizes an innovative Gripping Surface and 3D Stapling Technologies. The stapler is designed to reduce leaks without compromising perfusion. Such innovative launches are expected to impel the global anastomosis market growth throughout the forecast period. Some of the companies which are currently dominating the market are Medtronic PLC, LivaNova PLC, Getinge AB, Johnson & Johnson (Ethicon US, LLC), and Baxter International Inc. (Synovis Micro Companies Alliance Inc.)
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support